MedPath

Ranbaxy Laboratories Limited

🇨🇷Costa Rica
Ownership
-
Established
1996-08-30
Employees
-
Market Cap
-
Website

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
26
Registration Number
NCT00778245
Locations
🇨🇦

MDS Pharma Services, Montreal, Quebec, Canada

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
26
Registration Number
NCT00778115
Locations
🇺🇸

Gateway Medical Research, Inc., St. Charles, Missouri, United States

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
40
Registration Number
NCT00778284
Locations
🇺🇸

MDS Pharma Services, Phoenix, Arizona, United States

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-23
Last Posted Date
2008-10-23
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
22
Registration Number
NCT00778232
Locations
🇺🇸

PRACS Institute Ltd., Fargo, North Dakota, United States

Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-22
Last Posted Date
2008-10-22
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
24
Registration Number
NCT00777413
Locations
🇺🇸

AII pharma, Chapell Hill, North Carolina, United States

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
80
Registration Number
NCT00776217

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
32
Registration Number
NCT00776620
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
24
Registration Number
NCT00776672
Locations
🇺🇸

Gateway Medical Research Inc., St.charles, Missouri, United States

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
36
Registration Number
NCT00776646

Bioequivalence Study of Minocycline 100mg Tablets Under Fasting Conditions

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-10-21
Last Posted Date
2008-10-21
Lead Sponsor
Ranbaxy Laboratories Limited
Target Recruit Count
28
Registration Number
NCT00776542
Locations
🇺🇸

AII pharma, Chapell Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath